Frier Levitt published a legal analysis examining a D.C. Circuit ruling that drug manufacturers cannot unilaterally replace upfront 340B discounts with rebate models.

At Frier Levitt, we help clients thrive in a rapidly evolving healthcare, life sciences, and pharmacy landscape, through exceptional counsel, innovative strategies, and a relentless focus on excellence. For 25 years, Frier Levitt has been a trusted legal partner to the healthcare, life sciences and pharmacy industries. Founded by Daniel B. Frier and Jonathan E. Levitt, our firm has grown into a national boutique law firm with more than 50 attorneys, many of whom are also licensed healthcare professionals. Exclusively focused on healthcare, life sciences and pharmacy, Frier Levitt provides regulatory, transactional, and litigation counsel to clients across the spectrum—from providers, pharmacies, and manufacturers to investors, innovators, and life sciences companies. This singular focus allows us to combine legal insight with real-world clinical experience, delivering practical solutions to the complex challenges facing our clients. With offices in New Jersey and New York and a national reach, we serve clients across the country and are regularly recognized for our thought leadership, industry expertise, and results-driven approach.